EVE · ASX

EVE Health Group Limited (ASX:EVE)

AU$0.001

 0.0 (0.0%)
ASX:Live
09/12/2024 12:00:00 AM
Near Support Near Resistance Near 52 Week Low Near 52 Week High HALO Ords +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

EVE Overview

EVE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About EVE

Website

N/A

Telephone

Address

Description

EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. Its portfolio includes Omni Innovation, Meluka Australia, Jenbrook Australia, and Naturally Australian Products. It operates through the following segments: Jenbrook, Meluka, and Investment. The company was founded on October 1, 2003 and is headquartered in Subiaco, Australia.

EVE Price Chart

Key Stats

Market Cap

AU$5.27M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

AU$26.00

1 week

0%

1 month

0%

YTD

0%

1 year

0%

All time high

0.21

Key Fundamentals

EPS 3 yr Growth

-50.00%

EBITDA Margin

-72.00%

Operating Cashflow

-$1m

Free Cash Flow Return

-50.90%

ROIC

-71.20%

Interest Coverage

-44.00

Quick Ratio

1.80

Other Data

Shares on Issue (Fully Dilluted)

5274m

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EVE Announcements

Latest Announcements

Date Announcements

26 November 24

Results of Meeting

×

Results of Meeting

26 November 24

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

26 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 October 24

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

28 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

23 October 24

Quarterly Activities/Appendix 5B Cash Flow Report

×

Quarterly Activities/Appendix 5B Cash Flow Report

30 September 24

Date of AGM and Closing Date for Director Nominations

×

Date of AGM and Closing Date for Director Nominations

30 September 24

Annual Report to shareholders

×

Annual Report to shareholders

30 September 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 August 24

Sale of Robyndale Property

×

Sale of Robyndale Property

30 August 24

Sale of Robyndale Property (Amended)

×

Sale of Robyndale Property (Amended)

30 August 24

Preliminary Final Report

×

Preliminary Final Report

31 July 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Details of Auditor Appointment/Resignation

×

Details of Auditor Appointment/Resignation

02 April 24

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

28 February 24

Appendix 4D and Half Year Report

×

Appendix 4D and Half Year Report

31 January 24

Farm Sale and Funding Update

×

Farm Sale and Funding Update

31 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

24 November 23

New Constitution

×

New Constitution

23 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

21 November 23

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

21 November 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

25 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EVE Shortsell

Frequently Asked Questions

The current share price of EVE Health Group Limited (EVE:ASX) is AU$0.001.
The 52-week high share price for EVE Health Group Limited (EVE:ASX) is AU$0.00.
The 52-week low share price for EVE Health Group Limited (EVE:ASX)? is AU$0.00.
EVE Health Group Limited (EVE:ASX) does not pay a dividend.
EVE Health Group Limited (EVE:ASX) does not pay a dividend.
EVE Health Group Limited (EVE:ASX) has a franking level of 0.0%.
EVE Health Group Limited (EVE:ASX) is classified in the Healthcare.
The current P/E ratio for EVE Health Group Limited (EVE:ASX) is .